Drug Trial Radar · NCT05633654
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,514
Planned (sponsor's estimate)
Start
Dec 12, 2022
Primary completion
Jun 2027
Study completion Aug 2031
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- Collaborators
- Alliance Foundation Trials, LLC.; NSABP Foundation Inc; GBG Forschungs GmbH
- First posted
- Dec 1, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Conditions
- Triple Negative Breast Cancer
Interventions
Sacituzumab govitecan-hziy (SG)Drug
Administered intravenously
PembrolizumabDrug
Administered intravenously
CapecitabineDrug
Tablets administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Invasive Disease-free Survival (iDFS)Time frame: Up to 60 months
Locations
378 sites in 12 countries. Site status is shown where the registry gives one.
Alabama Oncology
Birmingham, Alabama · Recruiting
Clearview Cancer Institute
Huntsville, Alabama · Recruiting
Palo Verde Hematology Oncology
Glendale, Arizona · Recruiting
Mayo Clinic Hospital
Phoenix, Arizona · Withdrawn
Arizona Oncology Associates
Prescott Valley, Arizona · Withdrawn
Alta Bates Summit Medical Center
Berkeley, California · Recruiting
Community Cancer Institute
Clovis, California · Withdrawn
PIH Health Whittier Hospital
Downey, California · Recruiting
Compassionate Cancer Care Medical Group - Inc
Fountain Valley, California · Active not recruiting
Los Angeles Cancer Network
Los Angeles, California · Active not recruiting
USC Norris Comprehensive Cancer Center
Los Angeles, California · Withdrawn
Cedars-Sinai Cancer at Beverly Hills
Los Angeles, California · Recruiting
Hoag Memorial Hospital Presbyterian
Newport Beach, California · Recruiting
Emad Ibrahim, MD, INC
Redlands, California · Withdrawn
Sutter Institute for Medical Research
Sacramento, California · Recruiting
City of Hope (Duarte)
San Francisco, California · Recruiting
UCSF Medical Center
San Francisco, California · Recruiting
Sansum Clinic
Santa Barbara, California · Recruiting
Stockton Hematology Oncology Medical Group
Stockton, California · Recruiting
University of Colorado Cancer Center
Aurora, Colorado · Withdrawn
Norwalk Hospital
Danbury, Connecticut · Withdrawn
Stamford Hospital
Stamford, Connecticut · Recruiting
MedStar Georgetown University Hospital
Washington D.C., District of Columbia · Recruiting
MedStar Washington Hospital Center
Washington D.C., District of Columbia · Recruiting
Morton Plant Hospital - Bay Care
Clearwater, Florida · Withdrawn
University of Florida
Gainesville, Florida · Withdrawn
Mayo Clinic Florida
Jacksonville, Florida · Recruiting
Cancer Specialists of North Florida
Jacksonville, Florida · Recruiting
Jupiter Medical Center
Jupiter, Florida · Recruiting
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida · Recruiting
Midland Florida Clinical Research Center, L
Orange City, Florida · Withdrawn
Orlando Health
Orlando, Florida · Active not recruiting
Cancer Care Centers of Brevard, Inc
Palm Bay, Florida · Recruiting
Memorial Healthcare System
Pembroke Pines, Florida · Recruiting
Sacred Heart Medical Oncology Group
Pensacola, Florida · Withdrawn
Sylvester Comprehensive Cancer Center
Plantation, Florida · Recruiting
Cleveland Clinic Florida, Martin North Hospital
Stuart, Florida · Withdrawn
St. Joseph's Hospital
Tampa, Florida · Withdrawn
Weston Hospital
Weston, Florida · Withdrawn
University Cancer & Blood Center, LLC.
Athens, Georgia · Recruiting
Showing 40 of 378 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.